Lb Pharmaceuticals (LBRX) Shares Outstanding (Weighted Average) (2024 - 2026)

Lb Pharmaceuticals' Shares Outstanding (Weighted Average) history runs 3 years deep, the most recent figure standing at $28.2 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 7771.66% year-over-year to $28.2 million; the TTM figure through Mar 2026 stood at $28.2 million (up 7771.66% YoY), while the FY2025 annual figure was $8.0 million, up 2145.81% from the prior year.
• Shares Outstanding (Weighted Average) was $28.2 million for Q1 2026 at Lb Pharmaceuticals, up from $8.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $28.2 million in Q1 2026 to a low of $358229.0 in Q4 2024.
• Historically, Shares Outstanding (Weighted Average) has averaged $6.6 million across 3 years, with a median of $1.3 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Weighted Average) jumped 511.34% in 2025, then soared 7771.66% in 2026.
• A 3-year view of Shares Outstanding (Weighted Average) shows it stood at $358229.0 in 2024, then surged by 2145.81% to $8.0 million in 2025, then soared by 251.04% to $28.2 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $28.2 million (Q1 2026), $8.0 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.